Decentralized Clinical Trials

Helped a mobile vision center company decide whether to invest in building a long-term clinical trials business after pivoting during the pandemic.

Pivoting to Clinical Trials: Turning Pandemic Experience Into a Growth Engine

Helped a mobile vision center company evaluate whether to commit long-term to clinical trials after successfully pivoting during COVID-19.

Temperature-Controlled Packaging: From Diligence Insight to Market Expansion

Validated market growth, competitive positioning, and regulatory risk for a PE investor considering acquiring a reusable temperature-controlled packaging supplier.

Temperature-Controlled Packaging: Positioning for a Successful Exit

Produced an independent market study to educate buyers and strengthen the sale narrative for a PE-sponsored TCP company navigating post-pandemic market volatility.

Molecular Diagnostics: Making the Right Technology Choice

Helped a deadlocked board, founder, and management team resolve a strategic choice between a breakthrough technology and their established platform.

AI-Powered Liquid Biopsy: From Bench to Bedside

Developed market entry strategy and investor positioning for a noninvasive AI-driven imaging and analytics platform targeting real-time cancer detection.

AI Platform Strategy: From Open-Source Experiment to Ecosystem Engine

Helped an open-source healthcare data marketplace convert developer community traction into enterprise demand and prepare for Series A fundraising.

CDMO Due Diligence: Pinpointing Opportunity in a Complex Market

Validated market attractiveness, customer stickiness, and management strength for an investor acquiring a fast-growing contract development and manufacturing organization.

Contract Development and Manufacturing Organization (CDMO) for Aseptic Products

Provided commercial due diligence for a real estate investor evaluating a fast-growing CDMO, covering industry demand, competitive dynamics, and customer relationships.